drugset / Trial / NCT01679028

Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese

NCT01679028 ↗

Phase 1 Completed 20 enrolled Tasly Pharmaceuticals, Inc. Parexel · collab
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to see how safe an investigational new drug (T89) is and how well healthy Japanese subjects tolerate it when given two single doses and a multiple dose.

Timeline

Start
2012-08
Primary completion
2012-10
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject T89 Traditional medicine (herbal / TCM) 150 mg —
Subject T89 Traditional medicine (herbal / TCM) 225 mg —
Subject T89 Traditional medicine (herbal / TCM) 300 mg —

Indications

No indication recorded.